From the School of Hygiene and Public Health, Department of Epidemiology, The Johns Hopkins University, Baltimore, Md.
Controversies section editor: Phil B. Fontanarosa, MD, Senior Editor.
THE INCREASING USE of trials as vehicles for choosing among treatments
has fueled drives for standardizing the way trials are reported.1-5
These drives have been propelled by editors, frustrated readers, and meta-analysts
desiring the same basic information and counts.
Meinert CL. Beyond CONSORT: Need for Improved Reporting Standards for Clinical Trials. JAMA. 1998;279(18):1487–1489. doi:10.1001/jama.279.18.1487
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: